← Evidence map

Observational studyDiabetes, obesity & metabolism2020

Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes.

Concetta Irace et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

12 papers cite it

2020
2021
2022
2023
2024
2025
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 32037699